The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prediction of acute myeloid leukaemia risk in healthy individuals
Open accessAbstract
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure 1. The onset of such de novo AML cases is typically preceded by the accumulation of somatic mutations in preleukaemic haematopoietic stem and progenitor cells (HSPCs) that undergo clonal expansion 2,3. However, recurrent AML mutations also accumulate in HSPCs during ageing of healthy individuals who do not develop AML, a phenomenon referred to as age-related clonal haematopoiesis (ARCH)4-8. Here we use deep sequencing to analyse genes that are recurrently mutated in AML to distinguish between individuals who have a high risk of developing AML and those with benign ARCH. We analysed peripheral blood cells from 95 individuals that were obtained on average 6.3 years before AML diagnosis (pre-AML group), together with 414 unselected age- and gender-matched individuals (control group). Pre-AML cases were distinct from controls and had more mutations per sample, higher variant allele frequencies, indicating greater clonal expansion, and showed enrichment of mutations in specific genes. Genetic parameters were used to derive a model that accurately predicted AML-free survival; this model was validated in an independent cohort of 29 pre-AML cases and 262 controls. Because AML is rare, we also developed an AML predictive model using a large electronic health record database that identified individuals at greater risk. Collectively our findings provide proof-of-concept that it is possible to discriminate ARCH from pre-AML many years before malignant transformation. This could in future enable earlier detection and monitoring, and may help to inform intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, progression to hematological malignancies depends on the type and complexity of mutations in CHIP.2,5,6”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH-associated variants of the epigenetic writers and erasers Dnmt3a and Tet2, respectively, that affect the HSPC methylome have been shown to alter functions of monocyte-derived tissue M F and promote cardiovascular pathologies 31-34 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clone size, which is approximated by the variant allele fraction (VAF), has previously been shown to be an important predictor of risk for blood cancer1,17 and cardiovascular outcomes8,9.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
In the citing paper
“Both groups found that individuals with antecedent clonal hematopoiesis were at ~3 to 5-fold increased risk for developing AML in the subsequent years (Fig. 3A).”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
In the citing paper
“The effect of specific gene variants on various outcomes may be quite different, as has been found in AML 71.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,954
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Cited by
Sorted by citations
Clonal hematopoiesis in human aging and disease
Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156
“M. A. Sanders et al., MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML.”
InfluentialFundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Re, D. P. D., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 994
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Bolton, K. L., Ptashkin, R. N., Gao, T., Braunstein, L., Devlin, S. M., Kelly, D., Patel, M., Berthon, A., Syed, A., Yabe, M., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00710-0 · Cited by 751
Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges
Huang, S., Yang, J., Fong, S. J., & Zhao, Q. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.007 · Cited by 724
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
Chen, X., Gole, J., Gore, A., He, Q., Lü, M., Min, J., Yuan, Z., Yang, X., Jiang, Y., Zhang, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17316-z · Cited by 649
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Saygin, C., Matei, D., Majeti, R., Reizes, O., & Lathia, J. D. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.017 · Cited by 517
Clonal dynamics of haematopoiesis across the human lifespan
Mitchell, E., Chapman, M. S., Williams, N., Dawson, K. J., Mende, N., Calderbank, E. F., Jung, H., Mitchell, T. J., Coorens, T. H. H., Spencer, D. H., et al. (2022) · Nature · doi:10.1038/s41586-022-04786-y · Cited by 538
Bone marrow niches in haematological malignancies
Méndez‐Ferrer, S., Bonnet, D. A., Steensma, D. P., Hasserjian, R. P., Ghobrial, I. M., Gribben, J. G., Andreeff, M., & Krause, D. S. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0245-2 · Cited by 515
Dorsheimer, L., Assmus, B., Rasper, T., Ortmann, C. A., Ecke, A., Abou-El-Ardat, K., Schmid, T., Brüne, B., Wagner, S., Serve, H., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2018.3965 · Cited by 470
The evolutionary dynamics and fitness landscape of clonal hematopoiesis
Watson, C. J., Papula, A. L., Poon, G. Y. P., Wong, W. H., Young, A. L., Druley, T. E., Fisher, D. S., & Blundell, J. R. (2020) · Science · doi:10.1126/science.aay9333 · Cited by 444
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
Boettcher, S., Miller, P. G., Sharma, R., McConkey, M., Leventhal, M., Krivtsov, A. V., Giacomelli, A. O., Wong, W., Kim, J., Chao, S., et al. (2019) · Science · doi:10.1126/science.aax3649 · Cited by 441
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 463
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
Morita, K., Wang, F., Jahn, K., Hu, T., Tanaka, T. N., Sasaki, Y., Kuipers, J., Loghavi, S., Wang, S. A., Yan, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19119-8 · Cited by 411
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Jaiswal, S., & Libby, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0247-5 · Cited by 386
Kar, S. P., Quiros, P. M., Gu, M., Jiang, T., Mitchell, J., Langdon, R., Iyer, V., Barcena, C., Vijayabaskar, M. S., Fabre, M. A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01121-z · Cited by 377
The longitudinal dynamics and natural history of clonal haematopoiesis
Fabre, M. A., de Almeida, J. G., Fiorillo, E., Mitchell, E., Damaskou, A., Rak, J., Orrù, V., Marongiu, M., Chapman, M. S., Vijayabaskar, M. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04785-z · Cited by 374
Self-citationOgawa, S. (2019) · Blood · doi:10.1182/blood-2018-10-844621 · Cited by 382
Cancer as a disease of old age: changing mutational and microenvironmental landscapes
Laconi, E., Marongiu, F., & DeGregori, J. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0721-1 · Cited by 348
NPM1-mutated acute myeloid leukemia: from bench to bedside
Falini, B., Brunetti, L., Sportoletti, P., & Martelli, M. P. (2020) · Blood · doi:10.1182/blood.2019004226 · Cited by 355
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
Weeks, L. D., Niroula, A., Neuberg, D. S., Wong, W. J., Lindsley, R. C., Luskin, M. R., Berliner, N., Stone, R. M., DeAngelo, D. J., Soiffer, R. J., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200310 · Cited by 351
Daly, M. B., Pal, T., Maxwell, K. N., Churpek, J. E., Kohlmann, W. K., Al‐Hilli, Z., Arun, B., Buys, S. S., Cheng, H. H., Domchek, S. M., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.0051 · Cited by 320
Extensive heterogeneity in somatic mutation and selection in the human bladder
Lawson, A. R. J., Abascal, F., Coorens, T. H. H., Hooks, Y., O’Neill, L., Latimer, C., Raine, K., Sanders, M. A., Warren, A. Y., Mahbubani, K. T. A., et al. (2020) · Science · doi:10.1126/science.aba8347 · Cited by 311
Self-citationDistinction of lymphoid and myeloid clonal hematopoiesis
Niroula, A., Sekar, A., Murakami, M. A., Trinder, M., Agrawal, M., Wong, W. J., Bick, A. G., Uddin, M. M., Gibson, C. J., Griffin, G. K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01521-4 · Cited by 308
Caiado, F., Pietras, E. M., & Manz, M. G. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201541 · Cited by 289
Life histories of myeloproliferative neoplasms inferred from phylogenies
Williams, N., Lee, J., Mitchell, E., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A., Godfrey, A. L., Green, A. R., et al. (2022) · Nature · doi:10.1038/s41586-021-04312-6 · Cited by 285
Self-citationHallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 305
Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis
Heyde, A., Rohde, D., McAlpine, C. S., Zhang, S., Hoyer, F. F., Gerold, J. M., Cheek, D., Iwamoto, Y., Schloss, M. J., Vandoorne, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.049 · Cited by 267
Clonal expansion in non-cancer tissues
Kakiuchi, N., & Ogawa, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00335-3 · Cited by 252
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia
Uckelmann, H. J., Kim, S. M., Wong, E. M. C., Hatton, C., Giovinazzo, H., Gadrey, J. Y., Krivtsov, A. V., Rücker, F. G., Döhner, K., McGeehan, G. M., et al. (2020) · Science · doi:10.1126/science.aax5863 · Cited by 267
Application of Artificial Intelligence in Medicine: An Overview
Liu, P.-R., Lu, L., Zhang, J.-Y., Huo, T.-T., Liu, S.-X., & Ye, Z.-W. (2021) · Current Medical Science · doi:10.1007/s11596-021-2474-3 · Cited by 258
Leukemic stem cells and therapy resistance in acute myeloid leukemia
Stelmach, P., & Trumpp, A. (2023) · Haematologica · doi:10.3324/haematol.2022.280800 · Cited by 273
Libby (2019) · doi:10.1016/j.jacc.2019.06.007 · Cited by 247
DNA methylation disruption reshapes the hematopoietic differentiation landscape
Izzo, F., Lee, S. C., Poran, A., Chaligne, R., Gaiti, F., Gross, B., Murali, R. R., Deochand, S. D., Ang, C., Jones, P. W., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0595-4 · Cited by 236
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
Chen, J., Kao, Y.-R., Sun, D., Todorova, T. I., Reynolds, D. M., Narayanagari, S.-R., Montagna, C., Will, B., Verma, A. K., & Steidl, U. G. (2018) · Nature Medicine · doi:10.1038/s41591-018-0267-4 · Cited by 239
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Duncavage, E. J., Bagg, A., Hasserjian, R. P., Dinardo, C. D., Godley, L. A., Iacobucci, I., Jaiswal, S., Malcovati, L., Vannucchi, A. M., Patel, K. P., et al. (2022) · Blood · doi:10.1182/blood.2022015853 · Cited by 235
Monogenic and polygenic inheritance become instruments for clonal selection
Loh, P., Genovese, G., & McCarroll, S. A. (2020) · Nature · doi:10.1038/s41586-020-2430-6 · Cited by 210
Life histories of myeloproliferative neoplasms inferred from phylogenies.
Williams, N., Lee, J., Mitchell, E., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A. H., Godfrey, A. L., Green, A. R., et al. (2022) · RePEc: Research Papers in Economics · doi:10.17863/cam.80309 · Cited by 216
Rare variant associations with plasma protein levels in the UK Biobank
Dhindsa, R. S., Burren, O. S., Sun, B. B., Prins, B. P., Matelska, D., Wheeler, E., Mitchell, J., Oerton, E., Hristova, V. A., Smith, K. R., et al. (2023) · Nature · doi:10.1038/s41586-023-06547-x · Cited by 193
Burd, A. L., Levine, R. L., Ruppert, A. S., Mims, A. S., Borate, U., Stein, E. M., Patel, P. A., Baer, M. R., Stock, W., Deininger, M. W., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1089-8 · Cited by 195
Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
Chan, H. T., Chin, Y. M., Nakamura, Y., & Low, S. (2020) · Cancers · doi:10.3390/cancers12082277 · Cited by 192
Causes and consequences of clonal hematopoiesis
Weeks, L. D., & Ebert, B. L. (2023) · Blood · doi:10.1182/blood.2023022222 · Cited by 169
Increased somatic mutation burdens in normal human cells due to defective DNA polymerases
Robinson, P. S., Coorens, T. H. H., Palles, C., Mitchell, E., Abascal, F., Olafsson, S., Lee, B. C. H., Lawson, A. R. J., Lee-Six, H., Moore, L., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00930-y · Cited by 173
Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis
Yamashita, M., Dellorusso, P. V., Olson, O. C., & Passegue, E. A. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0260-3 · Cited by 197
Clonal hematopoiesis is associated with protection from Alzheimer’s disease
Bouzid, H., Belk, J. A., Jan, M., Qi, Y., Sarnowski, C., Wirth, S., Ma, L., Chrostek, M. R., Ahmad, H., Nachun, D., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02397-2 · Cited by 169
Mouhieddine, T. H., Sperling, A. S., Redd, R. A., Park, J., Leventhal, M. J., Gibson, C. J., Manier, S., Nassar, A. H., Capelletti, M., Huynh, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16805-5 · Cited by 176
Somatic Mutations in “Benign” Disease
Mustjoki, S. M., & Young, N. S. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2101920 · Cited by 169
Cardiovascular Disease, Aging, and Clonal Hematopoiesis
Evans, M. A., Sano, S., & Walsh, K. X. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032544 · Cited by 169
Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling
Caiado, F., Kovtonyuk, L. V., Gonullu, N. G., Fullin, J., Boettcher, S., & Manz, M. G. (2023) · Blood · doi:10.1182/blood.2022016835 · Cited by 161
Aßmus, B., Cremer, S., Kirschbaum, K., Culmann, D., Kiefer, K. C., Dorsheimer, L., Rasper, T., Abou‐El‐Ardat, K., Herrmann, E. M., Berkowitsch, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa845 · Cited by 168
Clonal haematopoiesis and dysregulation of the immune system
Belizaire, R., Wong, W. J., Robinette, M. L., & Ebert, B. L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00843-3 · Cited by 161
Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation
Gibson, C. J., Kim, H. T., Zhao, L., Murdock, H. M., Hambley, B., Ogata, A., Madero-Marroquin, R., Wang, S., Green, L., Fleharty, M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02286 · Cited by 168
JAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
Sano, S., Wang, Y., Yura, Y., Sano, M., Oshima, K., Yang, Y., Katanasaka, Y., Min, K.-D., Matsuura, S., Ravid, K., et al. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.013 · Cited by 170
Chromosomal alterations among age-related haematopoietic clones in Japan
Terao, C., Suzuki, A., Momozawa, Y., Akiyama, M., Ishigaki, K., Yamamoto, K., Matsuda, K., Murakami, Y., McCarroll, S. A., Kubo, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2426-2 · Cited by 150
Applications and analysis of targeted genomic sequencing in cancer studies
Bewicke‐Copley, F., Kumar, E. A., Palladino, G., Korfi, K., & Wang, J. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.10.004 · Cited by 164
Genomic copy number predicts esophageal cancer years before transformation
Killcoyne, S., Gregson, E., Wedge, D. C., Woodcock, D. J., Eldridge, M. D., de la Rue, R., Miremadi, A., Abbas, S., Blasko, A., Kosmidou, C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1033-y · Cited by 149
Self-citationArtificial intelligence in cancer diagnosis and therapy: Current status and future perspective
Sufyan, M., Shokat, Z., & Ashfaq, U. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107356 · Cited by 170
Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies
Lio, C. J., Yuita, H., & Rao, A. (2019) · Blood · doi:10.1182/blood.2019791475 · Cited by 152
Lenalidomide promotes the development of TP53 -mutated therapy-related myeloid neoplasms
Sperling, A. S., Guerra, V. A., Kennedy, J. A., Yan, Y., Hsu, J. I., Wang, F., Nguyen, A. T., Miller, P. G., McConkey, M. E., Barrios, V. A. Q., et al. (2022) · Blood · doi:10.1182/blood.2021014956 · Cited by 156
Jakobsen, N. A., Turkalj, S., Zeng, A. G. X., Stoilova, B., Metzner, M., Rahmig, S., Nagree, M. S., Shah, S., Moore, R., Usukhbayar, B., et al. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.05.010 · Cited by 130
Clonal hematopoiesis is associated with risk of severe Covid-19
Bolton, K. L., Koh, Y., Foote, M. B., Im, H., Jee, J., Sun, C.-H., Safonov, A. M., Ptashkin, R. N., Moon, J. H., Lee, J. Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26138-6 · Cited by 148
Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis
Saiki, R., Momozawa, Y., Nannya, Y., Nakagawa, M. M., Ochi, Y., Yoshizato, T., Terao, C., Kuroda, Y., Shiraishi, Y., Chiba, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01411-9 · Cited by 143
Altered RNA Processing in Cancer Pathogenesis and Therapy
Obeng, E. A., Stewart, C., & Abdel-Wahab, O. I. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0399 · Cited by 145
Nam, A. S., Dusaj, N., Izzo, F., Murali, R., Myers, R. M., Mouhieddine, T. H., Sotelo, J., Benbarche, S., Waarts, M., Gaiti, F., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01179-9 · Cited by 140
Zhang, C. R. C., Nix, D., Gregory, M., Ciorba, M. A., Ostrander, E. L., Newberry, R. D., Spencer, D. H., & Challen, G. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.11.008 · Cited by 137
“Despite the overall prevalence of CHIP, few of these individuals progress to hematopoietic malignancy [1, 2, 5, 7, 8].”
BackgroundLongitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects
Robertson, N. A., Latorre-Crespo, E., Terradas-Terradas, M., Lemos-Portela, J., Purcell, A. C., Livesey, B. J., Hillary, R. F., Murphy, L., Fawkes, A., MacGillivray, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01883-3 · Cited by 132
Clonal hematopoiesis: Mutation-specific adaptation to environmental change
Florez, M. A., Tran, B. T., Wathan, T. K., DeGregori, J., Pietras, E. M., & King, K. Y. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.05.006 · Cited by 129
Losing Sense of Self and Surroundings: Hematopoietic Stem Cell Aging and Leukemic Transformation
Verovskaya, E. V., Dellorusso, P. V., & Passegue, E. A. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.006 · Cited by 130
Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity
Cook, E. K., Luo, M., & Rauh, M. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.011 · Cited by 124
Pathophysiology of Acute Myeloid Leukemia
Wachter, F., & Pikman, Y. (2024) · Acta Haematologica · doi:10.1159/000536152 · Cited by 140
Multiparameter prediction of myeloid neoplasia risk
Gu, M., Kovilakam, S. C., Dunn, W. G., Marando, L., Bárcena, C., Mohorianu, I. I., Smith, A. G., Kar, S., Fabre, M. A., Gerstung, M., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01472-1 · Cited by 124
Sun, L., & Babushok, D. V. (2020) · Blood · doi:10.1182/blood.2019000940 · Cited by 126
Clonal hematopoiesis and risk of acute myeloid leukemia
Young, A. L., Tong, R. S., Birmann, B. M., & Druley, T. E. (2019) · Haematologica · doi:10.3324/haematol.2018.215269 · Cited by 116
Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis
Weinstock, J. S., Gopakumar, J., Burugula, B. B., Uddin, M. M., Jahn, N., Belk, J. A., Bouzid, H., Dániel, B., Miao, Z., Ly, N., et al. (2023) · Nature · doi:10.1038/s41586-023-05806-1 · Cited by 120
Bewersdorf, J. P., & Zeidan, A. M. (2020) · Cells · doi:10.3390/cells9102310 · Cited by 117
Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk
Cassidy, L. D., Young, A. R. J., Young, C. N. J., Soilleux, E. J., Fielder, E., Weigand, B. M., Lagnado, A., Brais, R., Ktistakis, N. T., Wiggins, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14187-x · Cited by 108
Zhou, Y., Huang, G., Cai, X., Liu, Y., Qian, B., & Li, D. (2024) · Biomarker Research · doi:10.1186/s40364-024-00649-y · Cited by 121
Relationship between clone metrics and clinical outcome in clonal cytopenia
Gallì, A., Todisco, G., Catamo, E., Sala, C. F., Elena, C., Pozzi, S., Bono, E. B., Ferretti, V. V., Rizzo, E., Molteni, E., et al. (2021) · Blood · doi:10.1182/blood.2021011323 · Cited by 106
Splicing factor mutations in hematologic malignancies
Chen, S., Benbarche, S., & Abdel-Wahab, O. I. (2021) · Blood · doi:10.1182/blood.2019004260 · Cited by 109
Palangat, M., Anastasakis, D. G., Fei, D. L., Lindblad, K. E., Bradley, R. K., Hourigan, C. S., Hafner, M., & Larson, D. R. (2019) · Genes & Development · doi:10.1101/gad.319590.118 · Cited by 101
HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults
Dharan, N. J., Yeh, P., Bloch, M., Yeung, M. M., Baker, D., Guinto, J., Roth, N., Ftouni, S., Ognenovska, K., Smith, D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01357-y · Cited by 108
Hecker, J. S., Hartmann, L., Rivière, J., Buck, M. C., van der Garde, M., Rothenberg‐Thurley, M., Fischer, L., Winter, S., Ksienzyk, B., Ziemann, F., et al. (2021) · Blood · doi:10.1182/blood.2020010163 · Cited by 102
Arends, C. M., Liman, T. G., Strzelecka, P. M., Kufner, A., Löwe, P., Huo, S., Stein, C. M., Piper, S. K., Tilgner, M., Sperber, P. S., et al. (2023) · Blood · doi:10.1182/blood.2022017661 · Cited by 99
Groarke, E. M., & Young, N. S. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.03.001 · Cited by 109
CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors
Reed, S. C., Croessmann, S., & Park, B. H. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2598 · Cited by 112
Bernstein, N., Chapman, M. S., Nyamondo, K., Chen, Z., Williams, N., Mitchell, E., Campbell, P. J., Cohen, R. L., & Nangalia, J. (2024) · Nature Genetics · doi:10.1038/s41588-024-01755-1 · Cited by 108
CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice
Dezern, A. E., Malcovati, L., & Ebert, B. L. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_239083 · Cited by 102
Danielsson, M., Halvardson, J., Davies, H., Moghadam, B. T., Mattisson, J., Rychlicka-Buniowska, E., Jaszczyński, J., Heintz, J., Lannfelt, L., Giedraitis, V., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0533-z · Cited by 96
Gao, T., Ptashkin, R. N., Bolton, K. L., Sirenko, M., Fong, C., Spitzer, B. G., Menghrajani, K. N., Ossa, J. A., Zhou, Y., Bernard, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20565-7 · Cited by 100
Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness
Ostrander, E. L., Kramer, A. C., Mallaney, C., Celik, H., Koh, W. K., Fairchild, J., Haussler, E., Zhang, C. R., & Challen, G. A. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.02.011 · Cited by 97
Clonal hematopoiesis and associated diseases: A review of recent findings
Asada, S., & Kitamura, T. (2021) · Cancer Science · doi:10.1111/cas.15094 · Cited by 104
Clonal hematopoiesis and risk for hematologic malignancy
Warren, J. T., & Link, D. C. (2020) · Blood · doi:10.1182/blood.2019000991 · Cited by 98
The Origin and Immune Recognition of Tumor-Specific Antigens
Apavaloaei, A., Hardy, M., Thibault, P., & Perreault, C. (2020) · Cancers · doi:10.3390/cancers12092607 · Cited by 95
Loizou, E., Banito, A., Livshits, G., Ho, Y.-J., Koche, R. P., Sánchez-Rivera, F. J., Mayle, A., Chen, C.-C., Kinalis, S., Bagger, F. O., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1391 · Cited by 88
The cell of origin and the leukemia stem cell in acute myeloid leukemia
Chopra, M., & Bohlander, S. K. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22805 · Cited by 95
Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
Arends, C. M., Weiß, M., Christen, F., Eulenberg-Gustavus, C., Rousselle, A., Kettritz, R., Eckardt, K., Chan, W., Hoyer, K., Frick, M., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.223305 · Cited by 89
Busque, L., Sun, M., Buscarlet, M., Ayachi, S., Feroz Zada, Y., Provost, S., Bourgoin, V., Mollica, L., Meisel, M., Hinterleitner, R., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000770 · Cited by 87
Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
Bewersdorf, J. P., Shallis, R. M., Stahl, M. F., & Zeidan, A. M. (2019) · Therapeutic Advances in Hematology · doi:10.1177/2040620718816698 · Cited by 88
Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
Taylor, J., & Lee, S. C.-W. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22784 · Cited by 88
Long Non-coding RNAs in Myeloid Malignancies
Zimța, A., Tomuleasa, C., Sahnoune, I., Calin, G. A., & Berindan‐Neagoe, I. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01048 · Cited by 87
Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population
van Zeventer, I. A., de Graaf, A. O., Salzbrunn, J. B., Nolte, I. M., Kamphuis, P., Dinmohamed, A. G., van der Reijden, B. A., Schuringa, J. J., Jansen, J. H., & Huls, G. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.04.006 · Cited by 85
Metadata
- Authors
- Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., Luben, R., Hayat, S., Wang, T. T., Zhao, Z., Cirlan, I., Pugh, T. J., Soave, D., Ng, K., Latimer, C., Hardy, C., Raine, K., Jones, D., Hoult, D., Britten, A., McPherson, J. D., Johansson, M., Mbabaali, F., Eagles, J., Miller, J. K., Pasternack, D., Timms, L., Krzyzanowski, P., Awadalla, P., Costa, R., Segal, E., Bratman, S. V., Beer, P., Behjati, S., Martincorena, I., Wang, J. C. Y., Bowles, K. M., Quirós, J. R., Karakatsani, A., La Vecchia, C., Trichopoulou, A., Salamanca-Fernández, E., Huerta, J. M., Barricarte, A., Travis, R. C., Tumino, R., Masala, G., Boeing, H., Panico, S., Kaaks, R., Krämer, A., Sieri, S., Riboli, E., Vineis, P., Foll, M., McKay, J., Polidoro, S., Sala, N., Khaw, K.-T., Vermeulen, R., Campbell, P. J., Papaemmanuil, E., Minden, M. D., Tanay, A., Balicer, R. D., Wareham, N. J., Gerstung, M., Dick, J. E., Brennan, P., Vassiliou, G. S., & Shlush, L. I.
- Affiliations
- University Health Network (CA)
- University of Cambridge (GB)
- University of Toronto (CA)
- Weizmann Institute of Science (IL)
- Clalit Health Services (IL)
- Ontario Institute for Cancer Research (CA)
- Wellcome Sanger Institute (GB)
- Centre international de recherche sur le cancer (FR)
- European Bioinformatics Institute (GB)
- University of East Anglia (GB)
- Gobierno del Principado de Asturias (ES)
- National and Kapodistrian University of Athens (GR)
- Hellenic Health Foundation (GR)
- Instituto Murciano de Investigación Biosanitaria (ES)
- Instituto de Salud Pública de Navarra (ES)
- University of Oxford (GB)
- Istituto per lo Studio e la Prevenzione Oncologica (IT)
- German Institute of Human Nutrition (DE)
- Federico II University Hospital (IT)
- German Cancer Research Center (DE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Imperial College London (GB)
- Italian institute for Genomic Medicine (IT)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Utrecht University (NL)
- Memorial Sloan Kettering Cancer Center (US)
- World Health Organization (CH)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- ORCID
- Abelson, Sagi
- Collord, Grace
- Ng, Stanley W. K.
- Weissbrod, Omer
- Barda, Noam
- Zuzarte, Philip C.
- Heisler, Lawrence
- Sundaravadanam, Yogi
- Luben, Robert
- Hayat, Shabina
- Zhao, Zhen
- Cirlan, Iulia
- Pugh, Trevor J.
- Soave, David
- Ng, Karen
- Latimer, Calli
- Raine, Keiran
- Jones, David
- Britten, Abigail
- McPherson, John D.
- Johansson, Mattias
- Eagles, Jenna
- Miller, Jessica K.
- Krzyzanowski, Paul
- Awadalla, Philip
- Costa, Rui
- Segal, Eran
- Bratman, Scott V.
- Beer, Philip
- Behjati, Sam
- Wang, Jean C. Y.
- Bowles, Kristian M.
- Karakatsani, Anna
- Trichopoulou, Antonia
- Huerta, José M.
- Barricarte, Aurelio
- Travis, Ruth C.
- Tumino, Rosario
- Masala, Giovanna
- Boeing, Heiner
- Panico, Salvatore
- Kaaks, Rudolf
- Krämer, Alwin
- Sieri, Sabina
- Vineis, Paolo
- Foll, Matthieu
- McKay, James
- Polidoro, Silvia
- Sala, Núria
- Khaw, Kay-Tee
- Vermeulen, Roel
- Campbell, Peter J.
- Papaemmanuil, Elli
- Minden, Mark D.
- Tanay, Amos
- Balicer, Ran D.
- Wareham, Nicholas J.
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- Venue
- Nature
- Published
- 2018-07
- Volume
- 559
- Issue
- 7714
- Pages
- 400-404
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6485381
- OpenAlex
- W2830196912
- Cited by
- 850
- References
- 49
- Citations by year
- 2026: 52 · 2025: 83 · 2024: 95 · 2023: 116 · 2022: 122 · 2021: 116 · 2020: 143 · 2019: 91 · 2018: 29
- FWCI
- 67.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, public-domain)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Apollo
- Funders
- World Health Organization
- Leukemia and Lymphoma Society
- Wellcome Trust (WT 098051, WT095663MA)
- Cancer Research UK (23015, 14136, 16491, 21777)
- National Institute for Health and Care Research (NF-SI-0512-10114, NF-SI-0512-10135, NF-SI-0617-10149)
- Generalitat de Catalunya
- Associazione Italiana per la Ricerca sul Cancro
- Clalit Health Services
- Abisch-Frenkel-Stiftung
- Hellenic Health Foundation
- Medical Research Council (MC_UU_12015/1, MC_PC_13048, MC_PC_12009, MR/N003284/1)
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III (RD12/0036/0018)
- European Regional Development Fund
- National Cancer Institute (P30CA008748)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, somatic mutations, clonal expansion, variant allele frequency
- MeSH terms
- Adult, Age Factors, Aged, Female, Health, Humans, Male, Middle Aged, Models, Genetic, Mutation, Leukemia, Myeloid, Acute, Prevalence, Mutagenesis, Disease Progression, Risk Assessment, Genetic Predisposition to Disease, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
